Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily
Clinical trial NCT01849341 · COMPLETED
Trial details
- NCT number
- NCT01849341
- Sponsor
- Fundación Pública Andaluza Progreso y Salud
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-12-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.